Van Plew News Today : Breaking News, Live Updates & Top Stories | Vimarsana

August 16, 1942 - October 31, 2021

The drug company Regeneron made an antibody drug designed to treat COVID-19 patients very quickly. This is the story of how they did it.

Dec 22, 2020 On a Saturday afternoon in March as COVID-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab. They had spent weeks frantically getting blood from early survivors across the globe and from mice with human-like immune systems — all to test thousands of potential treatments. Now it was time for results. The screen flashed totals of glowing green dots, hundreds or thousands in most samples. Then they saw some 10s, some twos and finally, zeroes. The researchers cheered and their boss sent out for champagne....

On a Saturday afternoon in March as Covid-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab. They had spent weeks frantically getting blood from early survivors across the globe and from mice with human-like immune systems — all to test thousands of potential treatments. Now it was time for results. The screen flashed totals of glowing green dots, hundreds or thousands in most samples. Then they saw some 10s, some twos and finally, zeroes. The researchers cheered and their boss sent out for champagne. No dots...

Marilynn Marchione In this Friday, March 13, 2020 photo provided by Regneron, members of the Infectious Disease team celebrate at their lab in New York state after confirming cells from Singapore are viable and that some make antibodies that bind to the coronavirus, suggesting they may have the potential to block it. (Regeneron via AP) December 20, 2020 - 9:06 PM On a Saturday afternoon in March as COVID-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab. They had spent weeks franticall...